NLRC5 ‐Deficient Macrophages Promote a Tumor‐Permissive Phenotype via AXL ‐ and MERTK ‐Mediated Efferocytosis
The FASEB Journal · 15.08.2026 · 40 (15)
DOI: 10.1096/fj.202504879r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 01.08.2026. Verfasst von Shambel Araya Haile und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, Proto-Oncogene Proteins, Receptor Protein-Tyrosine Kinases, Macrophages. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense (DOD), Tour de Cure (TDC), DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
The innate immune protein NLRC5 plays a key role in cancer immune surveillance. Reduced NLRC5 expression is associated with a poor prognosis for many types of cancers. Previously, we showed that mice with a myeloid‐specific deletion of Nlrc5 ( Nlrc5 mø‐KO ) develop gastric lymphoid lesions to Helicobacter infection resembling early‐stage marginal zone lymphoma. We hypothesized that NLRC5 deficiency may promote a tumor‐permissive microenvironment mediated by tumor‐associated macrophages (TAMs). Consistent with this hypothesis, splenic macrophages from Helicobacter ‐infected Nlrc5 mø‐KO mice had upregulated expression of genes encoding the TAM receptor tyrosine kinases, Axl and Mertk. The levels of AXL and MERTK gene expression and MERTK phosphorylation were increased in NLRC5 −/− THP‐1 macrophages when compared with WT cells. In response to Helicobacter stimulation, Nlrc5 −/− macrophages had significantly elevated anti‐inflammatory responses (IL‐10, TGF‐β, Socs1 , Socs3 ) compared with WT cells. Importantly, Nlrc5 −/− macrophages showed enhanced efferocytosis and reduced antigen presentation to CD8 + T cells. Pretreatment of macrophages with AXL and MERTK inhibitors (R428, UNC2025) resulted in reduced efferocytosis and phosphorylation of downstream signaling molecules, STAT3 and ERK1/2. We propose that defective NLRC5 signaling in macrophages leads to tumor‐permissive responses, thereby promoting the development of gastric lymphoid neogenesis to Helicobacter infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
- Department of Molecular and Translational Science, Monash University, Melbourne, Victoria, Australia.
- Department of Veterinary Sciences, Università di Pisa, Pisa, Italy.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
- Department of Immunology, Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
- Department of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Richard L Ferrero
Förderung
- U.S. Department of Defense (DOD)
- Tour de Cure (TDC)
- DHAC | National Health and Medical Research Council (NHMRC)
- German Academic Exchange Service (DAAD)
- MU | Faculty of Medicine, Nursing and Health Sciences, Monash University (FMNHS)
- EC | Erasmus+ (Еразъм+)
- Public Health Agency of Canada (PHAC)
- State Government of Victoria (VicGovAu)
Zitieren
APA
Haile, S. A., Gatta, A., Colon, N., Philpott, D. J., Kufer, T. A., Ying, L., Tong, D., & Ferrero, R. L. (2026). NLRC5 ‐Deficient Macrophages Promote a Tumor‐Permissive Phenotype via AXL ‐ and MERTK ‐Mediated Efferocytosis. The FASEB Journal, 40(15). https://doi.org/10.1096/fj.202504879r
Vancouver
Haile SA, Gatta A, Colon N, Philpott DJ, Kufer TA, Ying L, et al. NLRC5 ‐Deficient Macrophages Promote a Tumor‐Permissive Phenotype via AXL ‐ and MERTK ‐Mediated Efferocytosis. The FASEB Journal. 2026;40(15). doi:10.1096/fj.202504879r
BibTeX
@article{Haile2026,
author = {Haile, Shambel Araya and Gatta, Alessandra and Colon, Nina and Philpott, Dana J and Kufer, Thomas A and Ying, Le and Tong, Dongmei and Ferrero, Richard L},
title = {NLRC5 ‐Deficient Macrophages Promote a Tumor‐Permissive Phenotype via AXL ‐ and MERTK ‐Mediated Efferocytosis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {15},
doi = {10.1096/fj.202504879r}
}
EUVIMED